"Original antigenic sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants

Infect Control Hosp Epidemiol. 2022 Aug;43(8):1091-1092. doi: 10.1017/ice.2021.199. Epub 2021 May 3.

Maryam Noori¹, Seyed Aria Nejadghaderi^{2

3}, Nima Rezaei^{4

5

6}

¹ Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
² Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
³ School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁴ Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
⁶ Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

No abstract available

MeSH terms